XML 50 R12.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2015 1,578,962      
Balance at Dec. 31, 2015 $ 2 $ 358 $ (49,832) $ (3,442)
Share-based compensation 942 942
Net loss (10,310) (10,310)
Conversion of convertible notes into common stock (in shares) 8,091,103      
Conversion of convertible notes into common stock $ 8 12,148 12,156
Exercise of stock options (in shares) 13,460      
Exercise of stock options 22 22
Balance (in shares) at Dec. 31, 2016 38,131,303      
Balance at Dec. 31, 2016 $ 38 80,686 (60,142) 20,582
Share-based compensation 2,707 2,707
Net loss (12,308) (12,308)
Exercise of stock options (in shares) 87,357      
Exercise of stock options 144 144
Balance (in shares) at Dec. 31, 2017 4,246,519      
Balance at Dec. 31, 2017 $ 38 83,537 (72,450) 11,125
Restricted stock units vested and issued (in shares) 2,271      
Restricted stock units vested and issued
Share-based compensation 615 615
Net loss (3,584) (3,584)
Adjustments to opening balance for change in accounting principle 46 46
Exercise of stock options (in shares) 237      
Exercise of stock options 5 5
Balance (in shares) at Mar. 31, 2018 4,249,027      
Balance at Mar. 31, 2018 $ 38 84,157 (75,988) 8,207
Balance (in shares) at Dec. 31, 2017 4,246,519      
Balance at Dec. 31, 2017 $ 38 83,537 (72,450) 11,125
Net loss       (10,345)
Balance (in shares) at Sep. 30, 2018 4,253,100      
Balance at Sep. 30, 2018 $ 38 85,625 (82,719) 2,944
Balance (in shares) at Dec. 31, 2017 4,246,519      
Balance at Dec. 31, 2017 $ 38 83,537 (72,450) 11,125
Share-based compensation 2,774 2,774
Net loss (13,987) (13,987)
Sale of common stock and warrants, net of issuance costs of $200 (in shares) 5,333,332      
Sale of common stock and warrants, net of issuance costs of $200 $ 5 3,795 $ 3,800
Exercise of stock options (in shares) 2,140     2,488
Exercise of stock options $ 0 4 $ 4
Balance (in shares) at Dec. 31, 2018 4,845,697      
Balance at Dec. 31, 2018 $ 43 90,110 (86,361) 3,792
Balance (in shares) at Mar. 31, 2018 4,249,027      
Balance at Mar. 31, 2018 $ 38 84,157 (75,988) 8,207
Restricted stock units vested and issued (in shares) 4,073      
Restricted stock units vested and issued
Share-based compensation 738 738
Net loss (3,217) (3,217)
Adjustments to opening balance for change in accounting principle 30 30
Balance (in shares) at Jun. 30, 2018 4,253,100      
Balance at Jun. 30, 2018 $ 38 84,895 (79,175) 5,758
Restricted stock units vested and issued
Share-based compensation 730 730
Net loss (3,544) (3,544)
Balance (in shares) at Sep. 30, 2018 4,253,100      
Balance at Sep. 30, 2018 $ 38 85,625 (82,719) 2,944
Balance (in shares) at Dec. 31, 2018 4,845,697      
Balance at Dec. 31, 2018 $ 43 90,110 (86,361) 3,792
Restricted stock units vested and issued (in shares) 2,268      
Restricted stock units vested and issued $ 1 1
Share-based compensation 690 690
Net loss (3,665) (3,665)
Balance (in shares) at Mar. 31, 2019 4,847,965      
Balance at Mar. 31, 2019 $ 44 90,800 (90,026) 818
Balance (in shares) at Dec. 31, 2018 4,845,697      
Balance at Dec. 31, 2018 $ 43 90,110 (86,361) 3,792
Net loss       $ (11,208)
Exercise of stock options (in shares)      
Balance (in shares) at Sep. 30, 2019 6,825,183      
Balance at Sep. 30, 2019 $ 46 102,716 (97,568) $ 5,194
Balance (in shares) at Mar. 31, 2019 4,847,965      
Balance at Mar. 31, 2019 $ 44 90,800 (90,026) 818
Share-based compensation 696 696
Net loss (3,750) (3,750)
Reverse stock split fractional share true up (in shares) (494)      
Balance (in shares) at Jun. 30, 2019 4,847,471      
Balance at Jun. 30, 2019 $ 44 91,496 (93,776) (2,236)
Restricted stock units vested and issued (in shares) 25,158      
Restricted stock units vested and issued
Share-based compensation 756 756
Net loss (3,792) (3,792)
Sale of common stock and warrants, net of issuance costs of $200 (in shares) 1,741,667      
Sale of common stock and warrants, net of issuance costs of $200 $ 2 9,258 9,260
Conversion of convertible notes into common stock (in shares) 210,887      
Conversion of convertible notes into common stock 1,206 1,206
Balance (in shares) at Sep. 30, 2019 6,825,183      
Balance at Sep. 30, 2019 $ 46 $ 102,716 $ (97,568) $ 5,194